Anzeige
Mehr »
Login
Sonntag, 04.12.2022 Börsentäglich über 12.000 News von 678 internationalen Medien
Sofort handeln! Diese Perle wird Ihr Depot-Turbo! Aktie explodiert bereits
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J84E ISIN: US00287Y1091 Ticker-Symbol: 4AB 
Tradegate
02.12.22
21:54 Uhr
155,00 Euro
-0,36
-0,23 %
Branche
Pharma
Aktienmarkt
S&P 100
S&P 500
1-Jahres-Chart
ABBVIE INC Chart 1 Jahr
5-Tage-Chart
ABBVIE INC 5-Tage-Chart
RealtimeGeldBriefZeit
155,06155,6818:59
155,20155,5002.12.

Aktuelle News zur ABBVIE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrBristol Myers, AbbVie drugs shake up first-line prescribing among gastroenterologists - report17
ABBVIE Aktie jetzt für 0€ handeln
DoAbbVie gets reimbursement for Rinvoq in 5 Canadian provinces13
DoAbbVie Announces Provincial Reimbursement For RINVOQ For Rheumatoid Treatment308WASHINGTON (dpa-AFX) - AbbVie Inc. (ABBV) Thursday announced provincial reimbursement for RINVOQ for the treatment of rheumatoid arthritis and psoriatic arthritis in Alberta, New Brunswick,...
► Artikel lesen
DoAbbVie Announces Provincial Reimbursement for RINVOQ (upadacitinib) for the Treatment of Rheumatoid Arthritis and Psoriatic Arthritis in Alberta, New Brunswick, Ontario, Quebec and Saskatchewan2
DiAbbVie Inc. - 8-K, Current Report9
DiAbbVie CDR (CAD Hedged): AbbVie CDR (CAD Hedged) to pay dividend Feb. 2314
MoHere's What's Driving AbbVie's (ABBV) Outperformance This Year24
26.11.Better Dividend Stock: AbbVie or Viatris?76
25.11.Pharma Stock Roundup: MRK to Buy IMGO, ABBV's Skyrizi Gets EU Nod for New Indication10
25.11.AbbVie's Rinvoq granted NICE recommendation as ulcerative colitis treatment3
25.11.Teva and Allergan finalise terms of US opioid settlements worth $6.6bn combined41
25.11.ABBVIE: NICE recommends RINVOQ? (upadacitinib) As Treatment Option For Moderately to Severely Active Ulcerative Colitis in Adults5
24.11.AbbVie's (ABBV) Skyrizi Gets EU Nod for Crohn's Disease4
24.11.AbbVie CDR (CAD Hedged): AbbVie CDR (CAD Hedged) to trade on NEO Nov. 258
23.11.Could an Investment in AbbVie Give You $10,000 in Annual Dividend Income by Retirement?22
23.11.Want $10,000 in Annual Dividend Income by Retirement? Here's How Much You Should Invest in AbbVie Today.13
23.11.Teva, AbbVie's Allergan lock in $6.6B deal to settle thousands of US opioid lawsuits39
23.11.AbbVie's Skyrizi receives EC approval for active Crohn's disease4
23.11.AbbVie Skyrizi gets approval in EU for expanded use in Crohn's disease3
23.11.AbbVie Boosts Its Dividend: Is the Dividend King a Buy?29
Seite:  Weiter >>
399 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
8,9,56